PEAK6’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
PEAK6's ROIV Position: Q3 2026 in Review
PEAK6 opened a new position in Roivant Sciences (ROIV) in Q3 2026: 30,840 shares worth $1.13M. The stake represents ﹤0.01% of the portfolio and ranks #1514 among its holdings. This is a return to the name: PEAK6 previously reported a position in ROIV as recently as Q4 2024.
PEAK6 first reported a position in ROIV in Q4 2024 and has held it in 2 quarters since. 521 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- PEAK6 held 30,840 shares of Roivant Sciences worth $1.13M as of Q3 2026.
- Roivant Sciences was a new PEAK6 position in Q3 2026.
- Roivant Sciences made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #1514 holding.
- PEAK6 first reported a position in Roivant Sciences in Q4 2024 and has held it in 2 quarters since.
- 521 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.